12 assets in Radiodermatitis

Therapeutic assets addressing Radiodermatitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Flosteron Radiodermatitis	Cairo University	P4	BB (69)
Olea Europaea Oil Radiodermatitis	Cairo University	P4	BB (69)
Imtenan Oil Radiodermatitis	German University in Cairo	P2	B (57)
gr1014-cg 2.4% Radiodermatitis	Graegis Pharmaceuticals Ltd	P2	CCC (53)
gr1014-cg 4.7% Radiodermatitis	Graegis Pharmaceuticals Ltd	P2	CCC (53)
Dermaprazole 2% Radiodermatitis	Baylor College of Medicine	P1/2	CCC (48)
Akk Radiodermatitis	West China Hospital	P1	CC (43)
Calendula Radiodermatitis	OHSU Knight Cancer Institute	N/A	D (30)
Hydrocortisone Radiodermatitis	OHSU Knight Cancer Institute	N/A	D (30)
Qibei Jiedu Formula Radiodermatitis	LI FENG	N/A	D (30)
Sulfadiazine Radiodermatitis	OHSU Knight Cancer Institute	N/A	D (30)
Chamomile Radiodermatitis	Hospital Universitario Reina Sofia de Cordoba	P2	NR ()